Implantes dentários em pacientes sob terapêutica com bisfosfonatos: precauções, riscos e mitos
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Dentistry has advanced severely in recent years, through the advancement of oral
rehabilitation it has been possible to place implants. Some drug classes may have a
direct interaction with bone tissue and consequently affect dental treatment,
especially in oral rehabilitation carried out with implants. Bisphosphonates (BFs) are
a class of drugs prescribed for patients with bone resorptive diseases. The objective
of this work was to review the scientific literature on the use of bisphosphonates and
their possible adverse effects, with the aim of predicting unwanted interactions and
preventing risks. A search for articles was carried out using the Scielo, BIREME and
PubMed databases in the last 15 years. Osteonecrosis of the jaws associated with
the use of bisphosphonates (BIONJ) is an adverse effect that is characterized by
non-healing of exposed bone in the mandibular region and its origin is multifactorial,
compromising the quality of life of affected patients. The use of implants in patients
who underwent therapy with bisphosphonates does not reach the consensus of a
prohibition, most of the contraindications are in patients who are undergoing cancer
treatment and who make use of intravenous bisphosphonates. Professionals should
be aware of the different medications on the market and be aware of the factors that
can contribute to the onset of osteonecrosis, requiring a comprehensive analysis of
their patients and complete follow-up with medical professionals regarding possible
suspensions of medication that could favor the rehabilitations.
Description
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

